Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials
预测前列腺癌放射治疗的剂量反应：在随机 III 期 NRG/RTOG 0126 和 SAKK 09/10 试验中验证放射特征
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2025.01.017
Dal Pra, A; Ghadjar, P; Ryu, H M; Proudfoot, J A; Hayoz, S; Michalski, J M; Spratt, D E; Liu, Y; Schär, C; Berlin, A M; Zwahlen, D R; Simko, J P; Hölscher, T; Efstathiou, J A; Polat, B; Sandler, H M; Hildebrandt, G; Parliament, M B; Mueller, A-C; Dayes, I S; Plasswilm, L; Correa, R J M; Robertson, J M; Karrison, T G; Davicioni, E; Hall, W A; Feng, F Y; Pollack, A; Thalmann, G N; Nguyen, P L; Aebersold, D M; Tran, P T; Zhao, S G
